FDA Hosts Public Workshop to Improve Adverse Event Collection for Public Health Benefit

Summary

The FDA's Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research are hosting a public workshop to gather input on research approaches for assessing the public health benefit of collecting and reporting all adverse events, with the goal of issuing a request for proposal to partner with outside organizations to conduct this research.